Tremelimumab Antibody
Tremelimumab is a monoclonal antibody that inhibits the CTLA-4 immune checkpoint. It is frequently combined with Durvalumab in oncology research for solid tumors, including hepatocellular and non-small cell lung carcinomas, with applications in both in vitro mechanistic studies and in vivo preclinical models.
Product Specifications
Product Name Alternative
CTLA-4, CP675206, CP-675206, CP 675206, Ticilimumab, Tremelimumab
Target
Others, Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.05 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.3 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680873-100 1x 100 µL
P34 / cdk1 (CDK1/873), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
HA723836B 100 µL
Human Fas / CD95 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details